Industries > Pharma > Nasal Drug Delivery Technology Market Forecast 2020-2030
Back to Pharma Reports
Nasal Drug Delivery Technology Market Forecast 2020-2030

Nasal Drug Delivery Technology Market Forecast 2020-2030

Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres, Hospitals, Specialty Clinics, Vaccination Centres plus analysis on leading companies in Nasal Drug Delivery Technology

PUBLISHED: 30 March 2020
PAGES: 185
PRODUCT CODE: PHA0549
SUBMARKET: Medical Devices Therapeutic Drugs

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0549 Categories: , , Tags: , , , , , ,

covid-19

The Global Nasal Drug Delivery Technology Market is estimated at $44,385 m in 2019 and is expected to grow at a CAGR of 7.8% from 2020-2025. In 2019, the Global Nasal Drug Delivery Technology Market was dominated by the nasal sprays submarket which held 33.2% of the overall market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 185-page report you will receive 54 charts– all unavailable elsewhere.

The 185-page report provides clear detailed insight into the Global Nasal Drug Delivery Technology Market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology market.

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by the dosage form:
– Dosage Form: Nasal Sprays, Nasal Drops & Liquids, Nasal Gels, Nasal Powders
– Nasal Sprays: Non-pressurized Containers and Pressurized Containers

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by System:
– Nasal Unidose Devices
– Nasal Bi Dose Devices
– Nasal Multi Dose Devices

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by Application:
– Asthma
– Allergic and Non-Allergic Rhinitis
– Nasal Congestion

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by End User:
– Hospitals
– Ambulatory Surgery Center
– Specialty Clinics
– Vaccination Centers

• Revenue and growth forecasts from 2020 to 2030 for the leading national markets:
– United States
– Canada
– Brazil
– Mexico
– Rest of Latin America
– Germany
– UK
– Italy
– France
– Spain
– Nordic
– Benelux
– Rest of Western Europe
– Russia
– Poland
– Rest of Eastern Europe
– Japan
– China
– India
– Australia & New Zealand
– ASEAN
– Rest of Asia-Pacific
– GCC Countries
– South Africa
– North Africa
– Rest of MEA

Nasal Drug Delivery Technology Market Forecast 2020-2030

• This report profiles the leading companies that market nasal drug delivery devices:
– 3M Company
– Becton, Dickinson and Company
– GlaxoSmithKline plc
– Johnson & Johnson
– Merck & Co., Inc.
– Pfizer Inc.
– Teleflex Incorporated
– Naveh Pharma Ltd.
– OptiNose US, Inc.
– Pendopharm
– AptarGroup, Inc.

• This report provides qualitative analysis of the Global Nasal Drug Delivery Technology market. This report discusses the Porter’s Five Forces Analysis, as well as the Drivers and Challenges of this market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Digital Wound Care Management market. You find data, trends and predictions.

Buy our report today Nasal Drug Delivery Technology Market Forecast: Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres, Hospitals, Specialty Clinics, Vaccination Centres.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Nasal Drug Delivery Technology Market Forecast 2020-2030

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Nasal Drug Delivery Technology Market Forecast 2020-2030

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

      The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

      25 September 2023

      READ

      Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

      The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

      21 September 2023

      READ

      Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

      The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

      14 September 2023

      READ

      Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

      The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

      13 September 2023

      READ